Clinical Trials

Inclusion Criteria: 

• ≥ 18 years of age.
• Status post unilateral uncomplicated pars plana vitrectomy for epiretinal membrane or internal limiting membrane peel (i.e. for epiretinal membrane, vitreomacular traction, lamellar or macular hole).
• The same phakic status in the fellow eye.

Exclusion Criteria: 

• Prior diagnosis of glaucoma, glaucoma suspect, or ocular hypertension.
• Difference in lens status between the two eyes (phakic, pseudophakic, or aphakic).
• Preoperative anisometropia greater than 2.5 diopters.
• Current use of topical, oral, inhaled, injected, or other corticosteroids.
• Abnormalities of the iridocorneal angle, including neovascular glaucoma, ICE syndrome, peripheral anterior synechiae, and plateau iris, among others.
• Monocular status (fellow eye with visual acuity less than 20/100, or phthisical or enucleated/eviscerated fellow eye).
• History of prior vitreoretinal surgery in either eye.
• Pregnancy.
• Inability to remain supine for the duration of testing.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 9/27/22. Questions regarding updates should be directed to the study team contact.